Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 0.9522 USD -4.46% Market Closed
Market Cap: 32.9m USD

Wall Street
Price Targets

ITRM Price Targets Summary
Iterum Therapeutics PLC

Wall Street analysts forecast ITRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITRM is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

Lowest
Price Target
5.05 USD
430% Upside
Average
Price Target
5.1 USD
436% Upside
Highest
Price Target
5.25 USD
451% Upside
Iterum Therapeutics PLC Competitors:
Price Targets
APLLTD
Alembic Pharmaceuticals Ltd
12% Upside
CPH
Cipher Pharmaceuticals Inc
38% Upside
IPCALAB
IPCA Laboratories Ltd
17% Upside
SUPRIYA
Supriya Lifescience Ltd
12% Downside
SANOFI
Sanofi India Ltd
26% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
35% Upside
DPHARMA
Duopharma Biotech Bhd
15% Upside
300363
Porton Pharma Solutions Ltd
40% Upside

Revenue
Forecast

Revenue Estimate
Iterum Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Iterum Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Iterum Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-83%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ITRM's stock price target?
Price Target
5.1 USD

According to Wall Street analysts, the average 1-year price target for ITRM is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

Back to Top